Medical Procedure News

RSS

Alimera Sciences provides new data from Iluvien Phase 3 FAME clinical trials for DME

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.

28 May 2010

Osprey Biomedical rolls out Eagle Cervical Allograft Series in ATPS Preservation System

Osprey Biomedical, a global spinal allograft bio-implant company announced today it has begun the roll out of its Eagle Cervical Allograft Series being offered in its ATPS Preservation System.

28 May 2010

Positron Emission Mammography helps evaluate response to neoadjuvant chemotherapy: Study

In a recent study presented at the American Association of Cancer Research Annual Meeting in Washington, DC, researchers at the University of Texas MD Anderson Cancer Center showed that Positron Emission Mammography (PEM) helps evaluate response to neoadjuvant chemotherapy.

28 May 2010

St. Jude Medical's Epiducer lead delivery system for neurostimulation therapy receives CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Epiducer™ lead delivery system for neurostimulation therapy. Unveiled at the Neurosurgery 2010 Congress in Lyon, France, the Epiducer lead delivery system is the first of its kind, allowing introduction of S-Series perc-paddle leads as well as multiple lead arrays through a single percutaneous entry point.

27 May 2010

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat serious acute cardiovascular disorders and infectious diseases, has received a grant in the amount of $150,000 from the National Science Foundation to support the development of antimicrobial sutures. PolyMedix has developed a series of novel antimicrobial polymers for device and material applications, which it collectively calls the PolyCides™.

27 May 2010

$Toremifene reduces fracture risk in men with prostate cancer after initiation of androgen deprivation therapy$

Toremifene reduces fracture risk in men with prostate cancer after initiation of androgen deprivation therapy

GTx, Inc. today announced that additional study results from the Phase III clinical trial evaluating toremifene 80 mg for the prevention of fractures in men with prostate cancer on androgen deprivation therapy will be presented at the 2010 Annual Meeting of the American Urological Association being held in San Francisco May 29-June 3.

27 May 2010

Greater physician involvement leads to fewer low-yield exams

A new rule preventing medical support staff from completing orders for outpatient imaging exams that were likely to be negative resulted in a marked decrease in low-yield exams for patients, according to a study appearing in the June issue of Radiology.

27 May 2010

Diving "feet first" can prevent spinal cord injuries

Matt, a Dearborn, Mich. resident, is featured in an award-winning video "Shattered Dreams," commissioned by the University of Michigan's Department of Neurosurgery as part of an injury prevention effort. Public service announcements based on the video begin airing in southeastern Michigan movie theatres June 4 to spread the message of "feet first" to boaters and swimmers.

27 May 2010

FDA, EMA approve Repligen's proposal for Phase 3 re-read in RG1068 trial for pancreatic imaging

Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).

27 May 2010

Covidien launches V-Loc 90 knotless wound closure device

Covidien, a leading global provider of healthcare products, today announced the global launch of the V-Loc 90 device, expanding its family of V-Loc absorbable wound closure devices. This latest addition to Covidien's knotless wound closure product line received 510(k) clearance from the U.S. Food and Drug Administration on May 11, 2010.

27 May 2010

ART no longer part of free public health services in Denmark

In light of the need to prioritise public expenditure, the Danish goverment decided this month to implement a legislative amendment, so that Assisted Reproduction Treatment (ART) will no longer be part of the free public health services.

27 May 2010

Study finds improvement in detection of breast cancer in mammograms over 9-year period

Researchers analyzing 2.5 million screening mammograms performed on nearly one million women found discrimination of cancerous from non-cancerous lesions improved over a nine-year period. Results of the study are published in the online edition of the journal Radiology.

27 May 2010

Usage of shunts to direct blood flow to lungs can help kids born with hypoplastic left heart syndrome

A trial on shunts used to direct blood flow to the lungs, led by researchers at the University of Michigan's C.S. Mott Children's Hospital, will lead to better outcomes for kids worldwide born with hypoplastic left heart syndrome, the most common severe heart birth defect.

27 May 2010

Largest clinical trial to compare surgical treatments for congenital heart disease

Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.

27 May 2010

CREST study data published in The New England Journal of Medicine

Data from the CREST (Carotid Revascularization Endarterectomy vs. Stenting Trial) study were published today in The New England Journal of Medicine. In this trial, stenting and surgery had similar initial safety and longer-term outcomes for symptomatic and asymptomatic men and women. Adverse event rates of death, stroke and heart attack were also similar for both therapies.

27 May 2010

Cordis announces launch of ExoSeal Vascular Closure Device

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced the launch of the ExoSeal(TM) Vascular Closure Device. ExoSeal(TM) incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure. Cordis Corporation received CE-Marking approval for ExoSeal(TM) Vascular Closure Device in May 2010.

27 May 2010

Impulse Monitoring signs agreement to provide Tufts Medical Center IONM services

Impulse Monitoring, Inc. (IMI), a leading provider of intraoperative neurophysiological monitoring (IONM) services to hospitals, today announced that it has signed an agreement with Tufts Medical Center, Boston to provide comprehensive IONM services, including real-time physician oversight.

27 May 2010

Kensey Nash granted FDA 510(k) clearance for Meso BioMatrix ECM product

Kensey Nash Corporation, a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its second extracellular matrix (ECM) product, the Meso BioMatrix™ product.

27 May 2010

Abbott's TREK Coronary Dilatation Catheter receives European approval

Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.

26 May 2010

St. Jude Medical to evaluate cost-effectiveness of FFR for multivessel coronary artery disease

St. Jude Medical, Inc., a global medical device company, announced today at EuroPCR it will evaluate the incremental cost-effectiveness of Fractional Flow Reserve (FFR)-guided treatment for patients with multivessel coronary artery disease in the UK, Germany, France, Italy, Switzerland, Belgium and Canada. The analysis will also determine FFR's potential health and budget impact for each of the seven countries.

26 May 2010

Medical Procedure News

Alimera Sciences provides new data from Iluvien Phase 3 FAME clinical trials for DME

Osprey Biomedical rolls out Eagle Cervical Allograft Series in ATPS Preservation System

Positron Emission Mammography helps evaluate response to neoadjuvant chemotherapy: Study

St. Jude Medical's Epiducer lead delivery system for neurostimulation therapy receives CE Mark approval

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

Toremifene reduces fracture risk in men with prostate cancer after initiation of androgen deprivation therapy

Greater physician involvement leads to fewer low-yield exams

Diving "feet first" can prevent spinal cord injuries

FDA, EMA approve Repligen's proposal for Phase 3 re-read in RG1068 trial for pancreatic imaging

Covidien launches V-Loc 90 knotless wound closure device

ART no longer part of free public health services in Denmark

Study finds improvement in detection of breast cancer in mammograms over 9-year period

Usage of shunts to direct blood flow to lungs can help kids born with hypoplastic left heart syndrome

Largest clinical trial to compare surgical treatments for congenital heart disease

CREST study data published in The New England Journal of Medicine

Cordis announces launch of ExoSeal Vascular Closure Device

Impulse Monitoring signs agreement to provide Tufts Medical Center IONM services

Kensey Nash granted FDA 510(k) clearance for Meso BioMatrix ECM product

Abbott's TREK Coronary Dilatation Catheter receives European approval

St. Jude Medical to evaluate cost-effectiveness of FFR for multivessel coronary artery disease

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Latest News